0001181431-14-018866.txt : 20140509 0001181431-14-018866.hdr.sgml : 20140509 20140509171642 ACCESSION NUMBER: 0001181431-14-018866 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140507 FILED AS OF DATE: 20140509 DATE AS OF CHANGE: 20140509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 650271219 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALABRO JOSEPH M CENTRAL INDEX KEY: 0001218834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 14830227 MAIL ADDRESS: STREET 1: C/O PEDIATRIX MEDICAL GROUP-LEGAL DEPT., STREET 2: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 4 1 rrd408887.xml X0306 4 2014-05-07 0 0000893949 MEDNAX, INC. MD 0001218834 CALABRO JOSEPH M 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 President and COO Common Stock 2014-05-07 4 M 0 62500 27.715 A 289042 D Common Stock 2014-05-07 4 M 0 60490 28.025 A 349532 D Common Stock 2014-05-07 4 S 0 122990 56.9845 D 226542 D Common Stock 2014-05-08 4 M 0 14510 28.025 A 241052 D Common Stock 2014-05-08 4 S 0 14510 57.6896 D 226542 D Common Stock 8 I By Spouse Stock Options (Right to Buy) 27.715 2014-05-07 4 M 0 62500 27.715 D 2011-06-02 2018-06-02 Common Stock 62500 0 D Stock Options (Right to Buy) 28.025 2014-05-07 4 M 0 60490 28.025 D 2010-08-10 2017-08-10 Common Stock 60490 14510 D Stock Options (Right to Buy) 28.025 2014-05-08 4 M 0 14510 28.025 D 2010-08-10 2017-08-10 Common Stock 14510 0 D Sales made pursuant to Reporting Person's 10b5-1 trading plan. Sales of shares were executed in ninety-five (95) separate transactions with prices ranging from $56.53 to $57.56 for a weighted average sales price of $56.9845. Sales of shares were executed in sixty-one (61) separate transactions with prices ranging from $56.84 to $58.02 for a weighted average sales price of $57.6896. Dominic J. Andreano Attorney-in-Fact 2014-05-09